Skip to content

Effect of single intake of two different types of fish oil supplements on pharmacokinetics. -A randomized, double-blinded, crossover study-

Effect of single intake of two different types of fish oil supplements on pharmacokinetics. -A randomized, double-blinded, crossover study- - Effect of single intake of two different types of fish oil supplements on pharmacokinetics.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044188
Enrollment
16
Registered
2021-05-12
Start date
2021-05-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Intake of test food (single ingestion) - washout period - intake of control food (single ingestion). Intake of control food (single ingestion) - washout period - intake of test food (single ingestion)

Sponsors

FANCL Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age: 20 -65 years old 2. Sex : Male or Female 3. BMI:18.5 -25.0 kg/m2

Exclusion criteria

Exclusion criteria: 1. Patient with dyslipidaemia. 2. Subjects with severe liver diseases, digestive organ diseases, kidney diseases and heart diseases. 3. Subjects who have history of surgical resection of the gastrointestinal tract (except for appendectomy). 4. Subjects who have various symptoms of indigestion (diarrhea, stomach feels upset etc.). 5. Subjects who are bleeding at present or danger of bleeding (serious injuries and operations, etc.) 6. Can't stop to take a supplement or medicine including DHA, EPA during the study period. 7. Difficulty in collecting blood. 8. Smoker 9. Subjects who are planned to participate in other clinical study. 10. Subjects who intend to become pregnant or lactating. 11. Subjects who are judged as unsuitable for the study by the investigator for other reason.

Design outcomes

Primary

MeasureTime frame
Area under the blood concentration-time curve of delta-DHA.

Secondary

MeasureTime frame
Area under the blood concentration-time curve of DHA. Area under the blood concentration-time curve of EPA, delta-EPA. Blood concentration of DHA and EPA at each time point after ingestion of the test food. Cmax,Tmax of DHA or EPA.

Countries

Japan

Contacts

Public ContactMariko Hayashida

FANCL Corporation Research Institute, Health science research center

mariko1512@fancl.co.jp045-820-3667

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026